Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.35
-0.45 (-2.27%)
At close: Apr 23, 2026
Market Cap15.27B +44.2%
Revenue (ttm)1.90B +39.1%
Net Income337.87M +217.0%
EPS0.51 +111.0%
Shares Out810.02M
PE Ratio37.23
Forward PE26.66
Dividend0.70 (3.61%)
Ex-Dividend DateNov 24, 2025
Volume3,307,247
Average Volume4,518,683
Open19.85
Previous Close19.80
Day's Range19.05 - 19.85
52-Week Range14.85 - 40.10
Betan/a
RSI37.34
Earnings DateMay 8, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Founded 2018
Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements